Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg for neonatal Rhesus hemolytic disease
NL-OMON25873Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in Erythroblastosis fetalis (HDFN) comparing IVIg + conventional treatment with Placebo + conventional treatment (2 arms). Primary endpoints: Use of exchange transfusion and Number of exchange transfusions per infant. Started Aug 2006; status: active, not recruiting.
02
Drugs
immune globulin
03
Conditions
Erythroblastosis fetalis (HDFN)
Beyond the preview
Go deeper on NL-OMON25873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25873.